News

The drug is approved for use in combination with other agents, and will enable some patients to receive an all-oral therapy (without interferon injections), which represents a novel

Celsion’s reagent products are based on its newly acquired proprietary delivery platform technologies, TheraPlas and TheraSilence. TheraPlas and TheraSilence are designed for optimal transfection (intra-cellular delivery) of plasmid

The new line contains 44 vitamins and supplements with various benefits, including popular options such as probiotics, B-12, and multivitamins for both men and women. The radiance PLATINUM

The five-year APOE4 trial will involve more than 1,300 cognitively healthy older adults, ages 60 to 75, at high risk of developing symptoms of Alzheimer’s because they inherited

The Fast Track program of the FDA is designed to expedite the development and review of new drugs that are intended to treat serious or life-threatening conditions and

"This study underscores the importance of standardizing dosing instructions, which CHPA has long supported as a way of helping parents to appropriately treat their children’s symptoms with over-the-counter

Epilepsy is one of the most common neurological diseases, affecting 70 million worldwide and up to 5 million people in Latin America – and the successful treatment of

The sBLA for Avastin plus chemotherapy (paclitaxel and cisplatin or paclitaxel and topotecan) is based on data from the phase III GOG-0240 trial with an FDA action date

Discovered by Otsuka, the new investigational psychotropic compound brexpiprazole is being co-developed with Lundbeck. The NDA for brexpiprazole is supported by seven completed clinical Phase II or III